Thomas H. Jozefiak Email and Phone Number
Thomas H. Jozefiak work email
- Valid
- Valid
- Valid
Thomas H. Jozefiak personal email
- Valid
Thomas H. Jozefiak phone numbers
• R&D leader, entrepreneur, biomaterials developer, organic chemist, and materials scientist• Passionate about advancing polymers and biomaterials as therapeutic drugs and devices• Distinguished and diverse career in biomaterials, medical devices, drug delivery• Seasoned team leader with management experience in both small and large companies • Experienced in the evaluation of acquisition targets and in-licensing opportunities • Highly skilled “connector” adding value from external outreach, relationship building, and collaboration in product developmentCo-founder of two clinical stage start-ups, and seasoned R&D consultant , Dr. Jozefiak combines his experience in biomaterials and polymer therapeutics to solve problems in areas of high unmet medical need such as surgical adhesion prevention, surgical hemostasis, wound healing, drug delivery, and tissue engineering. He is an inventor or author on numerous patents and publications in diverse areas including resorbable biomaterials, therapeutic polymers, medicinal chemistry, polymer chemistry, and photographic imaging chemistry.
-
PolycalyxBoston, Ma, Us
-
Scientific FounderGlycologix Sep 2016 - PresentBeverly, Massachusetts, UsGLYCOLOGIX is a clinical stage glycobiologics company developing novel biomimetic proteoglycan materials with the potential to provide ground-breaking therapeutic solutions to the repair of dermis, cartilage and other connective tissues damaged by disease and aging. Glycologix is funded by SBIR Phase-1, -2 (NIH) and Angel Investment. Currently developing GLX-100 Bladder Instillate in clinical trials for treatment of Interstitial Cystitis. -
Co-Founder, Chief Scientific OfficerGlyscend Incorporated Jun 2017 - Dec 2024Lowell, Massachusetts, UsGLYSCEND Inc. is a clinical-stage startup advancing a revolutionary new approach to treating type 2 diabetes. Building on insights from bariatric surgery where immediate normalization of glucose homeostasis is observed, Glyscend is developing a non invasive biomaterials-based therapeutic that can be delivered within the current T2D care pathway. Glyscend is a VC funded company, and a winner of numerous grants and awards including the 2016 J&J "QuickFire Challenge". -
PrincipalJozefiak Biomaterials Consulting May 2013 - Jan 2020Experienced industry consultant helping start-up companies succeed by identifying clear, achievable, and critical R&D goals. Specializing in finding solutions to difficult chemistry problems and enabling robust product development for biomaterials-based medical devices and drug delivery products.
-
Vp, Biomaterials Science & EngineeringGenzyme Corp Feb 2007 - Apr 2013Paris, France, FrLeader of a multidisciplinary Biomaterials Science and Engineering department with capabilities in engineering, animal models, and analytical chemistry. Managed budget, hiring, resource allocation, and communication with senior management. Responsible for product support and new product development in areas of strategic importance including; adhesion barriers, viscosupplements, dermal fillers, and cartilage repair. Directed research programs in hemostasis, surgical sealants, and nanoparticle technology. Collaborated with business units to develop new program initiatives and evaluate external biomaterials opportunities. -
Senior Director, Medicinal ChemistryGenzyme Corp 2001 - Jan 2007Paris, France, FrTechnical manager for a medicinal chemistry department with responsibility for setting budgets, shifting resources among active projects, allocation of laboratory space, determining capital equipment needs, and hiring. Provided technical leadership for several lead optimization medicinal chemistry projects. Acted as outsourcing manager for compound library acquisition and contract research. Played a major role in seeking out and evaluating joint research opportunities and collaborations with other companies, academics and government labs.
-
Principal ScientistGeltex Pharmaceuticals, Inc. Sep 1997 - Dec 2000Contributing scientist and supervisor to a team of polymer synthetic chemists. Responsible for leading the GelTex anti-obesity polymer chemistry program. Developed unique in vitro fat-binding assays to identify polymers capable of modifying the physical state of lipids in GI fluid. Invented novel soluble polycations that are well tolerated in the GI tract. This work led to a polymer drug later brought to human clinical studies by Peptimmune (GT-389-255). Appointed as lead scientist with project management responsibilities for a multidisciplinary program seeking to discover novel inhibitors of active phosphate uptake in the GI tract. Acted as primary liaison to biochemistry, DMPK and pharmacology groups and to external CROs.
-
Senior Research ChemistEastman Kodak Sep 1992 - Aug 1997Rochester, New York, UsPerformed fundamental research on image dye aggregation in solution and applied these findings to the design of photographic elements in which cyan image dyes are formed in a microcrystalline state, providing superior color reproduction. Conducted studies on photochemically induced image dye decomposition and the stabilization of image dyes using a variety of stabilizing agents. Performed research on novel antioxidants as preservatives in color developer solutions. -
Postdoctoral FellowCaltech Jun 1990 - May 1992Pasadena, Ca, UsJoint postdoc position with research groups of Prof. Robert Grubbs and Prof. Nate Lewis. Performed electrochemical characterization of a new group of soluble polyacetylenes derived from the transition metal catalyzed ring opening metathesis polymerization (ROMP) of substituted cyclooctatetraenes. -
Product Development ChemistGe Plastics Jan 1989 - Apr 1990Riyadh, SaPerformed process optimization for scale-up of a new high performance polyetherimide thermoplastic. Translated lab scale experiments to pilot scale reactors. Synthesized aryl polyetherimides and novel silicone containing etherimide block copolymers.
Thomas H. Jozefiak Skills
Thomas H. Jozefiak Education Details
-
CaltechMaterials Chemistry -
University Of MinnesotaChemistry
-
University Of Massachusetts AmherstChemistry
-
Saint Peter'S UniversityChemistry
Frequently Asked Questions about Thomas H. Jozefiak
What company does Thomas H. Jozefiak work for?
Thomas H. Jozefiak works for Polycalyx
What is Thomas H. Jozefiak's role at the current company?
Thomas H. Jozefiak's current role is Biomaterials Innovator, Entrepreneur.
What is Thomas H. Jozefiak's email address?
Thomas H. Jozefiak's email address is li****@****aol.com
What is Thomas H. Jozefiak's direct phone number?
Thomas H. Jozefiak's direct phone number is +178148*****
What schools did Thomas H. Jozefiak attend?
Thomas H. Jozefiak attended Caltech, University Of Minnesota, University Of Massachusetts Amherst, Saint Peter's University.
What are some of Thomas H. Jozefiak's interests?
Thomas H. Jozefiak has interest in Cooking, Home Improvement, Reading, Crafts, Gourmet Cooking, Home Decoration.
What skills is Thomas H. Jozefiak known for?
Thomas H. Jozefiak has skills like Biotechnology, Biomaterials, R&d, Drug Discovery, Polymer Chemistry, Analytical Chemistry, Life Sciences, Technology Transfer, Chemistry, Polymers, Medical Devices, Research And Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial